Search Results - "Yanay, N."

Life or death by NFκB, Losartan promotes survival in dy2J/dy2J mouse of MDC1A by Elbaz, M, Yanay, N, Laban, S, Rabie, M, Mitrani-Rosenbaum, S, Nevo, Y

“…Inflammation and fibrosis are well-defined mechanisms involved in the pathogenesis of the incurable Laminin α 2-deficient congenital muscular dystrophy…”
Get full text

Improved efficacy and reduced osteoporosis following methylprednisolone – Nano liposomes treatment in mdx mice by Yanay, N, Turgeman, K, Elbaz, M, Issa, B, Rabie, M, Barenholz, Y, Nevo, Y

Get full text

Maintenance of inspiratory muscle training in COPD patients: one year follow-up by Weiner, P, Magadle, R, Beckerman, M, Weiner, M, Berar-Yanay, N

“…In most chronic obstructive pulmonary disease (COPD) patients, dyspnoea and functional exercise capacity may improve as a result of inspiratory muscle training…”
Get full text

P.8.10 Losartan up-regulates NF κ B signaling pathway and favors survival versus apoptosis in the dy2J/dy2J mouse model of Congenital Muscular Dystrophy by Elbaz, M, Yanay, N, Gelb, S, Rabie, M, Rosenbaum, S. Mitrani, Nevo, Y

“…Congenital Muscular Dystrophy (CMD) is a group of genetic disorders characterized by progressive loss of muscle strength and integrity. Merosin deficient…”
Get full text

G.P.211 by Yanay, N, Kasis, I, Elbaz, M, Laban, S, Issa, B, Rabie, M, Mitrani-Rosenbaum, S, Nevo, Y

“…Merosin deficient congenital muscular dystrophy type 1A (MDC1A) is a devastating incurable disorder of childhood. We previously studied the effect of…”
Get full text

P.8.11 Glatiramer acetate improved motor conduction velocity in dy2J /dy2J mouse peripheral neuropathy by Yanay, N, Nevo, Y, Felig, Y, Elbaz, M, Gelb, S, Mitrani-Rosenbaum, S, Rabie, M

“…The dy2J /dy2J mouse model of laminin α 2-deficient congenital muscular dystrophy (MDC1A) has prominent peripheral neuropathy with slowed conduction. The…”
Get full text

T.P.6 Combination anti-inflammatory and anti-fibrotic treatment in muscular dystrophy – The more the better? by Kassis, I, Yanay, N, Elbaz, N, Brunschwig, Z, Ettinger, K, Nevo, Y

“…Abstract Congenital muscular dystrophy is an incurable disorder with no effective treatment. Anti-inflammatory and anti-fibrotic agents have been suggested as…”
Get full text

P4.24 Glatiramer acetate (Copaxone) decreases macrophage infiltration and increases muscle strength in mdx mouse model of Duchenne muscular dystrophy by Brunschwig, Z, Yanay, N, Aga-Mizrachi, S, Ettinger, K, Elbaz, M, Kassis, I, Felig, Y, Rabbie, M, Nevo, Y

Get full text

P3.48 Losartan improves muscle strength and ameliorates fibrosis in the dy2J/dy2J mouse model of merosin deficient congenital muscular dystrophy by Elbaz, M, Aga-Mizrachi, S, Yanay, N, Dadush, O, Ettinger, K, Brunschwig, Z, Rabie, M, Barak, V, Nevo, Y

Get full text

The cumulative effect of long-acting bronchodilators, exercise, and inspiratory muscle training on the perception of dyspnea in patients with advanced COPD by Weiner, P, Magadle, R, Berar-Yanay, N, Davidovich, A, Weiner, M

“…Dyspnea is a common complaint during daily activities in patients with advanced COPD. The mechanisms underlying dyspnea and the appropriate treatment…”
Get more information

Long-acting bronchodilators in premenstrual exacerbation of asthma by MAGADLE, R, BERAR-YANAY, N, WEINER, P

“…Premenstrual exacerbation (PME) of asthma occurs during the 5–10 days leading up to the menses and can be demonstrated in about 40% of asthmatic females. Peak…”
Get full text

Hypercalcaemia in systemic lupus erythematosus by Berar-Yanay, N, Weiner, P, Magadle, R

“…Hypercalcaemia is a common electrolyte abnormality. The vast majority of patients will be shown to have either hyperparathyroidism or malignancy. In less than…”
Get full text

DMD TREATMENT: ANIMAL MODELS by Konikov-Rozenman, J., Yanay, N., Rabie, M., Nevo, Y.

Get full text

DMD TREATMENT: ANIMAL MODELS: P.202Low Kindlin-2 levels in patients and mouse model of Duchenne muscular dystrophy by Konikov-Rozenman, J., Yanay, N., Rabie, M., Nevo, Y.

Get full text

EP.64Clinical characteristics of children with Duchenne and Becker muscle dystrophy in Israel by Goldfarb, I., Yanay, N., Aharoni, S., Levine, H., Rabie, M., Constantini, N., Nevo, Y.

Get full text

The perception of dyspnoea in patients with asthma, before and following treatment with inhaled glucocorticosteroids by WEINER, P., BERAR-YANAY, N., DAVIDOVICH, A., MAGADLE, R., WEINER, M.

“…This study was designed in order to establish the perception of breathlessness during rest and while breathing against resistance, in patients with asthma,…”
Get full text

P.246 - Characterization of molecular pathophysiology in muscular dystrophy by next generation RNA sequencing using DMD and CMD mouse models by Yanay, N., Elbaz, M., Konikov, J., Elgavish, S., Rabie, M., Mitrani-Rosenbaum, S., Nevo, Y.

Get full text

Characterization of molecular pathophysiology in muscular dystrophy by next generation RNA sequencing using DMD and CMD mouse models by Yanay, N., Elbaz, M., Konikov, J., Elgavish, S., Rabie, M., Mitrani-Rosenbaum, S., Nevo, Y.

Get full text

P.148 - Improved efficacy and reduced osteoporosis following methylprednisolone – Nano liposomes treatment in mdx mice by Yanay, N., Turgeman, K., Elbaz, M., Issa, B., Rabie, M., Barenholz, Y., Nevo, Y.

Get full text

Fever with dyspnea and swollen bilateral subclavicular area in a drug addict by Magadle, R, Weiner, P, Sotzkover, A, Mizrahi-Reuveni, M, Yanay, N B

Get full text